IRS Releases Tax Guidance for Cannabis Industry
The Internal Revenue Service (“IRS”) last Thursday released updated guidance on a stand-alone web page for the state-legal marijuana industry. The new guidance covers the rules for IRC Section 280E, income reporting, reporting case transactions over $10,000, cash payment options, estimating tax payments, and keeping financial records.
“A key component in promoting the highest degree of voluntary compliance on the part of taxpayers is helping them understand and meet their tax responsibilities while also enforcing the law with integrity and fairness to all,” the web page states.
This update appears to be responsive to a Treasury Department internal watchdog report that was released in April. The department’s inspector general for tax administration had criticized IRS for failing to adequately advise taxpayers in the marijuana industry about compliance with federal tax laws.
In a related FAQ, the IRS goes into further detail about specific issues that are particularly problematic for the marijuana industry, including general tax obligations, payment plans, penalties that can be incurred in an audit, deductions that businesses can and cannot make under IRC Sections 280E and 471 concerning calculation of costs of goods sold, and more detailed obligations concerning cash payments over $10,000.
While the new guidance will presumably provide some consistency to the IRS’s treatment of the industry, we strongly recommend that businesses engage competent and experienced tax advisors and counsel to lower tax risk associated with operating a cannabis business.
Contact Dan Garfield, dgarfield@mcallistergarfield.com, 720-722-0048, if you have questions about this IRS guidance or need assistance with entity structuring entity to help minimize the tax burden the cannabis industry faces.
Related Article
Emerging Trends In Psychedelic Laws: Implications for Practitioners
As the psychedelic renaissance continues, legal landscapes globally are evolving rapidly. What was once a fringe area of medical research and therapy is now moving towards mainstream acceptance, driven by promising results in clinical trials and changing public perceptions. For practitioners, these shifts present both exciting opportunities and complex challenges. This blog post explores emerging […]
McAllister Law Office – Psychedelic Law Update – June 2024
1. With Sean McAllister as one of their lawyers, The Church of The Eagle and The Condor is recognized as the third religious organization authorized to use ayahuasca in the United States. In a career highlight, I was honored to one of five lawyers representing The Church of The Eagle and The Condor (“CEC”) in […]
Navigating New Realms: The Crucial Role Of Legal Guidance In Psychedelic Business Start-Ups
In recent years, the interest in psychedelics for therapeutic purposes has surged, offering a promising frontier in both medical science and entrepreneurship. However, the burgeoning field of psychedelic businesses also presents a unique set of legal challenges. For start-ups in this industry, navigating the complex regulatory environment is not just about compliance, but also about […]